Abstract
BackgroundGenomic screening uncovered interferon-gamma (IFNγ) pathway defects in tumours refractory to immune checkpoint blockade (ICB). However, its non-mutational regulation and reversibility for therapeutic development remain less understood.ObjectiveWe aimed to identify...
Published Version (
Free)
Join us for a 30 min session where you can share your feedback and ask us any queries you have